NeoPrediX AG

We’re thrilled to attend the Synova Associates LLC 𝗣𝗲𝗿𝗶𝗻𝗮𝘁𝗮𝗹 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 𝗙𝗼𝗿𝘂𝗺 from November 10-14 at the beautiful Sunseeker Resort Charlotte Harbor, Florida. This year, we’re sharing a booth with our friends at Dräger , where we’ll be showcasing our new approach to 𝗷𝗮𝘂𝗻𝗱𝗶𝗰𝗲 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 - from screening to treatment. Together, we’re introducing innovative solutions designed to support healthcare providers and improve outcomes for newborns. If you’re attending, make sure to stop by our booth and check out what we are working on. We can’t wait to connect with leaders dedicated to improving maternal and neonatal health! #PerinatalCare #NeonatalHealth #Innovation #SynovaPLF

𝗔 𝗦𝗶𝗹𝗲𝗻𝘁 𝗖𝗿𝗶𝘀𝗶𝘀 𝗶𝗻 𝗠𝗮𝘁𝗲𝗿𝗻𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵: 𝗧𝗵𝗲 𝗥𝗶𝘀𝗲 𝗼𝗳 𝗗𝗲𝗮𝗱𝗹𝘆 𝗛𝗶𝗴𝗵 𝗕𝗹𝗼𝗼𝗱 𝗣𝗿𝗲𝘀𝘀𝘂𝗿𝗲 𝗶𝗻 𝗣𝗿𝗲𝗴𝗻𝗮𝗻𝗰𝘆  The Daily Montanan recently spotlighted a troubling trend: rates of high blood pressure during pregnancy, a primary driver of preeclampsia, are on the rise in the U.S. and posing serious risks to mothers and babies alike. For those of us working to advance maternal and neonatal health, this article brings urgency to our mission to address preventable complications in pregnancy. Read the full article here: https://lnkd.in/eQk7tN3J by Katheryn Houghton An excellent read that highlights what’s really happening in our country and how we are gambling with maternal mortality by not implementing tools to change these statistics. It’s time for a change. If you’re a clinician with insights or opinions on this urgent issue, we want to hear from you! Join us in transforming maternal health by helping to develop and refine solutions that predict and prevent high-risk pregnancy complications. At NeoPrediX, our mission is to make early intervention possible—𝗕𝗲𝗰𝗮𝘂𝘀𝗲 '𝘄𝗲 𝗱𝗶𝗱𝗻’𝘁 𝗸𝗻𝗼𝘄' 𝗶𝘀 𝗻𝗼 𝗹𝗼𝗻𝗴𝗲𝗿 𝗮𝗻 𝗼𝗽𝘁𝗶𝗼𝗻. #maternalhealth #preeclampsia #predictiveanalytics #innovation 

𝗪𝗼𝗿𝗹𝗱 𝗣𝗿𝗲𝗺𝗮𝘁𝘂𝗿𝗶𝘁𝘆 𝗠𝗼𝗻𝘁𝗵 is here, shining a spotlight on the global impact of preterm birth. Each year, 1 in 10 babies are born too soon, with conditions like preeclampsia significantly raising the risk of extremely preterm birth. Check out our latest 𝗶𝗻𝗳𝗼𝗴𝗿𝗮𝗽𝗵𝗶𝗰 for a closer look at these important statistics and help us spread awareness. Together, we can support families and work toward healthier outcomes for every baby. #WorldPrematurityMonth #PreeclampsiaAwareness #EarlyBirth

𝗪𝗼𝗿𝗹𝗱 𝗣𝗿𝗲𝗺𝗮𝘁𝘂𝗿𝗶𝘁𝘆 𝗠𝗼𝗻𝘁𝗵 is here, shining a spotlight on the global impact of preterm birth. Each year, 1 in 10 babies are born too soon, with conditions like preeclampsia significantly raising the risk of extremely preterm birth. Check out our latest 𝗶𝗻𝗳𝗼𝗴𝗿𝗮𝗽𝗵𝗶𝗰 for a closer look at these important statistics and help us spread awareness. Together, we can support families and work toward healthier outcomes for every baby. #WorldPrematurityMonth #PreeclampsiaAwareness #EarlyBirth

A recent study in BMJ Paediatrics Open sheds light on the challenges of managing neonatal jaundice, especially in areas with limited healthcare resources. The article highlights that “timely recognition of clinically significant hyperbilirubinemia is crucial” to prevent severe complications, yet high costs and logistical barriers limit access to early detection tools. 𝗔𝘁 𝗡𝗲𝗼𝗣𝗿𝗲𝗱𝗶𝗫, 𝘄𝗲’𝗿𝗲 𝗰𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗱 𝘁𝗼 𝘀𝗼𝗹𝘃𝗶𝗻𝗴 𝘁𝗵𝗶𝘀 𝗶𝘀𝘀𝘂𝗲. Our 𝗷𝗮𝘂𝗻𝗱𝗶𝗰𝗲 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝘁𝗼𝗼𝗹 leverages predictive analytics to provide early, reliable risk assessments, helping clinicians make proactive decisions that reduce unnecessary treatments and prioritize high-risk cases. By making jaundice screening more accessible, we aim to close the gap. Let’s continue to push for innovations that ensure every baby gets the healthy start they deserve! See the article by Shahryar Mir 𝗕𝗲𝗿𝘁𝗵𝗲 𝘃𝗮𝗻 𝗱𝗲𝗿 𝗚𝗲𝗲𝘀𝘁 Jasper Been  https://lnkd.in/eMnBuCDB #NeoPrediX #JaundiceManagement #MaternalHealth #NeonatalCare

Don’t miss our CEO Thorsten Waloschek’s key takeaways and reflections on the #HLTH conference. It sounds like it was an incredible event with exciting insights for the future of healthcare!

𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? 💡 Women with preeclampsia are at 𝗱𝗼𝘂𝗯𝗹𝗲 𝘁𝗵𝗲 𝗿𝗶𝘀𝗸 𝗼𝗳 𝗵𝗲𝗮𝗿𝘁 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗮𝗻𝗱 𝘀𝘁𝗿𝗼𝗸𝗲 later in life. Preeclampsia isn’t just a pregnancy complication—it can have lasting effects on a woman’s health. At NeoPrediX, we’re working on predictive tools to help identify this risk early, providing mothers with the care and information they need to protect their long-term health. #PreeclampsiaAwareness #HeartHealth #MaternalHealth #NeoPrediX

Our CEO, Thorsten Waloschek, will be attending 𝗛𝗟𝗧𝗛 𝟮𝟬𝟮𝟰  in Las Vegas, from October 20 - 23. We’re thrilled to join some of the brightest minds in healthcare and innovation to discuss the future of predictive analytics in 𝗺𝗮𝘁𝗲𝗿𝗻𝗮𝗹 𝗮𝗻𝗱 𝗻𝗲𝗼𝗻𝗮𝘁𝗮𝗹 𝗰𝗮𝗿𝗲. If you’ll be at HLTH and would like to meet with Thorsten to explore how NeoPrediX is transforming maternal and neonatal outcomes with our cutting-edge predictive algorithms, please reach out! Let’s connect and explore new possibilities in healthcare together. #HLTH2024 #PredictiveAnalytics #MaternalHealth #NeonatalCare #HealthcareInnovation #NeoPrediX #TechInHealthcare

 𝗔 𝗛𝗲𝗮𝗿𝘁𝗯𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗟𝗼𝘀𝘀 𝗧𝗵𝗮𝘁 𝗦𝗵𝗼𝘂𝗹𝗱 𝗡𝗲𝘃𝗲𝗿 𝗛𝗮𝗽𝗽𝗲𝗻 💔 We are deeply saddened by the recent story of 𝗦𝗮𝗿𝗮 𝗦𝗲𝘄𝗮𝗹𝗱, a mother who tragically lost her life due to complications from preeclampsia shortly after giving birth to twins. Despite reassurances that her condition was stable, Sara’s health deteriorated rapidly, leaving behind her newborns and a devastated family. Sara’s story is one of many that highlight the devastating effects of preeclampsia, a leading cause of maternal mortality worldwide, affecting millions of women each year. At 𝗡𝗲𝗼𝗣𝗿𝗲𝗱𝗶𝗫, we are committed to preventing tragedies like Sara’s. We are developing innovative 𝗽𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝘁𝗼𝗼𝗹𝘀 to detect early signs of preeclampsia, giving healthcare providers more time to intervene and save lives. Preeclampsia can be silent and fast-acting, which is why 𝗲𝗮𝗿𝗹𝘆 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 is critical. Our mission is to ensure no more families experience such a heartbreaking loss by equipping clinicians with the insights they need to act sooner. Sara’s story is a reminder of why our work matters. We honor her memory by continuing to fight for a future where no mother or child is lost to this condition. Together, we can make a difference. #MaternalHealth #PreeclampsiaAwareness #NeonatalCare #PredictiveAnalytics #NeoPrediX #HealthcareInnovation

"The rate of hypertensive disorders in pregnancy, including preeclampsia, has almost doubled over the past decade, rising from 4.4% in 2010 to 9.4% in 2021. This increase highlights the need for innovative, preventive healthcare solutions to address these risks, particularly in underserved populations." – JAMA, 2024 (Contemporary OB/GYN) At NeoPrediX, we believe that technology can help prevent tragic outcomes by providing clinicians with predictive tools to identify and manage high-risk pregnancies earlier. As maternal health challenges grow, especially with conditions like preeclampsia, the time for change is now. Read to learn more about these rising trends in pregnancy-related hypertensive disorders and ask us how NeoPrediX is stepping up to protect mothers and babies. #Preeclampsia #MaternalHealth #HealthcareInnovation #PredictiveAnalytics #NeonatalCare Celeste Krewson Rodney McLaren Mariam Ayyash Majid Shaman, MD, FACOG Huda Al-Kouatly Jill Jin